Product Details
| Product Name:
PAT-505 |
CAS No.:
1782070-22-7 |
| Purity:
98.84% |
Supply Ability:
10g |
| Release date:
2025/09/12 |
Product Introduction
Bioactivity
| Name | PAT-505 |
| Description | PAT-505 is an orally available, selective and potent inhibitor of autologous epidermal growth factor (IC50 2 nM in Hep3B cells, 9.7 nM in human blood, 62 nM in mouse plasma). |
| In vivo | PAT-505 is an effective, selective, and non-competitive inhibitor, exhibiting significant inhibition of ATX activity in plasma and liver tissues upon oral administration. Therapeutic dosing of PAT-505 in Stelic mice model of non-alcoholic steatohepatitis (NASH) resulted in a modest but significant improvement in fibrosis, with only slight improvements in hepatocyte ballooning and liver inflammation. In choline-deficient, high-fat NASH diet model, PAT-505 treatment effectively reduced liver fibrosis, without significant effects on steatosis, hepatocyte ballooning, or inflammation[1]. |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 30 mg/mL (63.30 mM), Sonication is recommended.
|
| Keywords | PAT-505 | PAT505 | PAT 505 | EGFR | Autotaxin |
| Inhibitors Related | (S)-Afatinib | Osimertinib | Lidocaine Hydrochloride hydrate | Lapatinib | Afatinib Dimaleate | Erlotinib hydrochloride | Erlotinib | Neratinib | Afatinib | Chalcone | Genistein | Gefitinib |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:2098884-53-6
$1980.00
-
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$66.00
|
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-06-02 |
|
|
$2800.00
|
VIP2Y
|
TargetMol Chemicals Inc.
|
2026-04-21 |
|
|
$99.00
|
|
Amikon Limited
|
2019-09-06 |
|
|
$179.00
|
VIP2Y
|
TargetMol Chemicals Inc.
|
2026-05-11 |
United States